ArticleFrontiers in immunology2023

Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab.

Wenling Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.